EUVIMEDEUVIMED entdecken
Crossref

Lifetime Disability-Adjusted Life-Year Assessment of Indolent Systemic Mastocytosis

Michael Mounié, Hélène Derumeaux Burel, Laurent Molinier, Nadège Costa, Cristina Bulai Livideanu

The Journal of Allergy and Clinical Immunology: In Practice · 2025

DOI: 10.1016/j.jaip.2024.12.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025. Verfasst von Michael Mounié und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Economic Unit, Department of Medical Information, University Hospital Center of Toulouse, Toulouse, France; EQUITY research team, Center for E…. Hauptthemen laut MEDLINE: Mastocytosis, Systemic, Disability-Adjusted Life Years. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Centre Hospitalier Universitaire de Toulouse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Indolent systemic mastocytosis (ISM) is a rare disease associated with numerous and diverse symptoms that significantly affect patients' overall health and psychological, emotional, and professional well-being, ultimately affecting the quality of life. OBJECTIVE: To estimate the disability-adjusted life-years (DALY) of ISM to assess the burden for patients and society. METHODS: We used prospective and retrospective data on symptoms and quality of life from a population with ISM recruited at the French expert center CEREMAST, to estimate disability weight allowing DALY calculation. An agent-based model was developed to assess the DALY of ISM over lifetime more accurately. RESULTS: Prospective data were available for 168 patients with ISM. A wide variety of symptoms were assessed, with 12.7 (±5.9) symptoms per patient and a huge impact on quality of life. The emotional dimension and impact on social life were also affected. Finally, we estimated the DALY per patient to be 4.56 to 8.79, representing 89 to 168 per 100,000 inhabitants. The DALY of ISM is comparable to that of lymphoma, leukemia, and psoriasis. CONCLUSIONS: To our knowledge, this is the first study to focus on the DALY of ISM. Despite differences in disease characteristics (such as prevalence, mortality, and age at diagnosis), DALY allows for the ranking of conditions and provides a better understanding of the disease burden. These data may help research prioritization by offering valuable information to health care policymakers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastocytosis, SystemicDisability-Adjusted Life YearsHumansMaleFemaleMiddle AgedQuality of LifeAdultAgedRetrospective StudiesProspective StudiesFranceYoung AdultAged, 80 and overAdolescentCost of Illness

Stichwörter der Autor:innen

BurdenDisability-adjusted life-yearsIndolent systemic mastocytosisQuality of lifeSymptoms

Autor:innen und Institutionen

  • Health Economic Unit, Department of Medical Information, University Hospital Center of Toulouse, Toulouse, France; EQUITY research team, Center for Epidemiology and Research in Population Health, UMR 1295, University To…
  • Health Economic Unit, Department of Medical Information, University Hospital Center of Toulouse, Toulouse, France.
  • CEREMAST, Dermatology Department, University Hospital, Toulouse, France.

Förderung

  • Centre Hospitalier Universitaire de Toulouse

Zitieren

APA

Mounié, M., Burel, H. D., Molinier, L., Costa, N., & Livideanu, C. B. (2025). Lifetime Disability-Adjusted Life-Year Assessment of Indolent Systemic Mastocytosis. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2024.12.034

Vancouver

Mounié M, Burel HD, Molinier L, Costa N, Livideanu CB. Lifetime Disability-Adjusted Life-Year Assessment of Indolent Systemic Mastocytosis. The Journal of Allergy and Clinical Immunology: In Practice. 2025. doi:10.1016/j.jaip.2024.12.034

BibTeX
@article{Mouni2025,
  author = {Mounié, Michael and Burel, Hélène Derumeaux and Molinier, Laurent and Costa, Nadège and Livideanu, Cristina Bulai},
  title = {Lifetime Disability-Adjusted Life-Year Assessment of Indolent Systemic Mastocytosis},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2025},
  doi = {10.1016/j.jaip.2024.12.034}
}
Kostenlos starten →